Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.11.2011 | Case report

Ciclosporin/colchicine

Myopathy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Halim MMA, Al-Otaibi T, Gheith O, Adel H, Musaad A, Vareed B, Pillai DS, Said T, Nair P, Nampoory MRN.Early progression of amyloidosis in a renal transplant recipient with familial mediterranean fever. Transplant International 24 (Suppl. 2): 288-289 abstr. P-244, Sep 2011. Available from: URL: http://dx.doi.org/10.1111/j.1432-2277.2011.01351.x - Kuwait Halim MMA, Al-Otaibi T, Gheith O, Adel H, Musaad A, Vareed B, Pillai DS, Said T, Nair P, Nampoory MRN.Early progression of amyloidosis in a renal transplant recipient with familial mediterranean fever. Transplant International 24 (Suppl. 2): 288-289 abstr. P-244, Sep 2011. Available from: URL: http://​dx.​doi.​org/​10.​1111/​j.​1432-2277.​2011.​01351.​x - Kuwait
Metadaten
Titel
Ciclosporin/colchicine
Myopathy: case report
Publikationsdatum
01.11.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113760-00033

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Treprostinil

Case report

Etanercept

Case report

Imatinib